Association of the ADORA2A receptor and CD73 polymorphisms with epilepsy
- PMID: 37063258
- PMCID: PMC10090369
- DOI: 10.3389/fphar.2023.1152667
Association of the ADORA2A receptor and CD73 polymorphisms with epilepsy
Abstract
Single-nucleotide polymorphisms are connected with the risk of epilepsy on occurrence, progress, and the individual response to drugs. Progress in genomic technology is exposing the complex genetic architecture of epilepsy. Compelling evidence has demonstrated that purines and adenosine are key mediators in the epileptic process. Our previous study found the interconnection of P2Y12 receptor single-nucleotide polymorphisms and epilepsy. However, little is known about the interaction between the purine nucleoside A2A receptor and rate-limiting enzyme ecto-5'-nucleotidase/CD73 and epilepsy from the genetic polymorphism aspect. The aim of the study is to evaluate the impact of A2AR and CD73 polymorphisms on epilepsy cases. The study group encompassed 181 patients with epilepsy and 55 healthy volunteers. A significant correlation was confirmed between CD73 rs4431401 and epilepsy (p < 0.001), with TT genotype frequency being higher and C allele being lower among epilepsy patients in comparison with healthy individuals, indicating that the presence of the TT genotype is related to an increased risk of epilepsy (OR = 2.742, p = 0.006) while carriers of the C allele demonstrated a decreased risk of epilepsy (OR = 0.304, p < 0.001). According to analysis based on gender, the allele and genotype of rs4431401 in CD73 were associated with both male and female cases (p < 0.0001, p = 0.026, respectively). Of note, we found that A2AR genetic variants rs2267076 T>C (p = 0.031), rs2298383 C>T (p = 0.045), rs4822492 T>G (p = 0.034), and rs4822489 T>G (p = 0.029) were only associated with epilepsy in female subjects instead of male. It is evident that the TT genotype and T allele of rs4431401 in CD73 were genetic risk factors for epilepsy, whereas rs2267076, rs2298383, rs4822492, and rs4822489 polymorphisms of the A2AR were mainly associated with female subjects.
Keywords: A2A receptor; CD73; epilepsy; purinergic receptor; single-nucleotide polymorphism.
Copyright © 2023 Shi, Wang, Liu, Zhang, Deng, Hu, Yang, Wang, Chen, Zuo, Liu, Zheng, Yang, Illes and Tang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
CD73 polymorphisms are associated with schizophrenia.Purinergic Signal. 2024 May 17. doi: 10.1007/s11302-024-10004-3. Online ahead of print. Purinergic Signal. 2024. PMID: 38758511
-
Genetic Polymorphism of ADORA2A Is Associated With the Risk of Epilepsy and Predisposition to Neurologic Comorbidity in Chinese Southern Children.Front Neurosci. 2020 Nov 11;14:590605. doi: 10.3389/fnins.2020.590605. eCollection 2020. Front Neurosci. 2020. PMID: 33262686 Free PMC article.
-
The association between Adenosine A2A receptor gene polymorphisms and attention deficit hyperactivity disorder in Korean children.Gene. 2023 Aug 5;876:147503. doi: 10.1016/j.gene.2023.147503. Epub 2023 May 21. Gene. 2023. PMID: 37220831
-
Adenosine A2a Receptor Polymorphisms and Susceptibility to Anxiety Disorders.Iran J Child Neurol. 2024 Fall;18(4):9-21. doi: 10.22037/ijcn.v18i4.43928. Epub 2024 Sep 29. Iran J Child Neurol. 2024. PMID: 39478950 Free PMC article. Review.
-
Complex regulation of ecto-5'-nucleotidase/CD73 and A2AR-mediated adenosine signaling at neurovascular unit: A link between acute and chronic neuroinflammation.Pharmacol Res. 2019 Jun;144:99-115. doi: 10.1016/j.phrs.2019.04.007. Epub 2019 Apr 5. Pharmacol Res. 2019. PMID: 30954629 Review.
Cited by
-
CD73 polymorphisms are associated with schizophrenia.Purinergic Signal. 2024 May 17. doi: 10.1007/s11302-024-10004-3. Online ahead of print. Purinergic Signal. 2024. PMID: 38758511
-
Therapeutic Efficacy of Intermittent Ketogenesis in Modulating Adenosine Metabolism, Immune Response, and Seizure Severity in Refractory Temporal Lobe Epilepsy: A Pilot Human Study.Inflammation. 2025 Feb 7. doi: 10.1007/s10753-025-02264-x. Online ahead of print. Inflammation. 2025. PMID: 39920557
References
-
- Augusto E., Gonçalves F. Q., Real J. E., Silva H. B., Pochmann D., Silva T. S., et al. (2021). Increased ATP release and CD73-mediated adenosine A2A receptor activation mediate convulsion-associated neuronal damage and hippocampal dysfunction. Neurobiol. Dis. 157, 105441. 10.1016/j.nbd.2021.105441 - DOI - PubMed
-
- Barros-Barbosa A. R., Ferreirinha F., Oliveira Â., Mendes M., Lobo M. G., Santos A., et al. (2016). Adenosine A2Areceptor, and ecto-5'-nucleotidase/CD73 are upregulated in hippocampal astrocytes of human patients with mesial temporal lobe epilepsy (MTLE). Purinergic Signal 12 (4), 719–734. 10.1007/s11302-016-9535-2 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials